openPR Logo
Press release

Malignant Ascites Treatment Market Opportunity Analysis - 2026

08-07-2018 03:49 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Malignant Ascites Treatment Market Opportunity Analysis - 2026

Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant peritoneal effusion or malignant ascites. Malignancies that are most commonly associated with malignant ascites are cancers of breast, liver, ovary, lungs, lymphoma, and colon. In ascites condition, lymph glands in the body gets blocked and lead to ascites symptoms including low blood pressure, loss of sleep, fatigue, and skin problems.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1775

Key symptoms in malignant ascites are abdominal pain or discomfort, shortness of breath, swelling of the abdomen, leg or ankle swelling, constipation, and weight gain. Diagnosis of ascites can be done by ultrasound, x-ray test, CT scans, and physical examination. The survival rate of these patients is very low, although with suitable treatment such as paracentesis, chemotherapy, and surgeries are available. Various conventional treatment for malignant ascites include chemotherapy, shunting, paracentesis, and use of drugs such as spironolactone and spironolactone. Cirrhosis of the liver is the most common cause of ascites but other conditions such as kidney failure, heart failure, cancer or infection can also cause ascites.

Malignant Ascites Treatment Market – Dynamics

Rising prevalence of cirrhosis is a major factor for growth of the malignant ascites market. For instance, according to a study published in World Journal of Gastroenterology 2011, over 50% of patients develop ascites within 10 years diagnosis. According to a published article in Journal of Clinical and Translational Hepatology 2014 showed advancements in ascites condition is related with poor prognosis, with a mortality of 15% at one year and 44% at the five year follow up. Moreover, favorable reimbursement policies like 2010 Patient Protection and Affordable Care Act (PPACA) and increasing incidence of cancer are also propelling the market growth. For instance, according to 2018 American Cancer Society report, cancer was responsible for 609,640 deaths in the U.S. Furthermore, key company adopt market strategies such as acquisition are propelling the market growth, For instance, 2016 NanoAntibiotics acquired LAT Pharma LLC, an early-stage biotechnology company famous for developing new medicines to treat life-threatening complications of liver cirrhosis.

However, stringent regulations and complications associated with ascites treatment such as internal bleeding after paracentesis treatment, exposure of radiation in chemotherapy may hinder growth of the market over the forecast period. For instance, According to report published in 2017 Experimental & Molecular Medicine showed that radiation can induce toxicities in non-tumorous liver tissues that may limit the course of therapy or have serious chronic side effects, including late fibrosis.

Malignant Ascites Treatment Market – Regional Insights

On the basis of region, malignant ascites treatment market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America accounts for the largest share in the global malignant ascites treatment market size, owing to high healthcare expenditure, well-developed technology, and increasing prevalence of cirrhosis are accelerating growth of the malignant ascites treatment market in this region. For instance, according to study published in 2015 Journal of Clinical Gastroenterology showed prevalence of cirrhosis in the U.S. was approximately 0.27%, corresponding to 633,323 adults.

Table of Content (ToC) at a glance @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1775

Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to increasing prevalence of cirrhosis. For instance, according to a study published in 2015 BMJ Open Gastroenterology, hospitalization from viral hepatitis cirrhosis decreased by 10% between 2006 to 2010, however, non-viral hepatitis cirrhosis and alcoholic cirrhosis exhibited an increase of 35% and 33% in China.

Malignant Ascites Treatment Market – Competitive Landscape

Key players operating in the global malignant ascites treatment market include PharmaCyte Biotech Inc., Sequana Medical, Fresenius SE & Co. KGaA, BioVie, BD, Medtronic plc, and GI Supply, Actavis Elizabeth LLC, Mylan Pharmaceuticals Inc., GE Healthcare, Trion Pharma, Siemens AG, and Fresenius Biotech. Major players are focused towards adopting strategies such as collaboration, and increasing R&D funding to strengthen their product portfolio and retain their position in the market, For instance, BioVie’s Lead Compound BIV201 received FDA Orphan-Drug Designation for the treatment of ascites in 2016

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malignant Ascites Treatment Market Opportunity Analysis - 2026 here

News-ID: 1167099 • Views: 767

More Releases from Coherent Market Insights

Ethyl Mercaptan Market: Strengthening Demand for Effective Industry | Arkema S.A …
The organosulfur compound ethyl mercaptan, also known as ethanethiol, is a clear toxic liquid with a distinct odour that was named the world's stinkiest substance in the Guinness Book of World Records in 2000.The scope and objective of the study are included in the Ethyl Mercaptan Market research report. In addition, the report highlights the report's key market segments and players. It also discusses industry trends, with an emphasis on
Gamma Polyglutamic Acid Market To Steal Growth Being Into A Frenzy Of Innovation …
The amino acid glutamic acid is bipolymerized to form polyglutamic acid. Peptide bonds form between the glutamic acid amino group and the carboxyl group at the end of the glutamic acid side chain in gamma polyglutamic acid. The scope and objective of the study are included in the Gamma Polyglutamic Acid Market research report. In addition, the report highlights the report's key market segments and players. It also discusses industry
PVC Packaging Materials Market Insights, Shaping A New Growth Cycle: 2028 | Reli …
Due to its properties such as light weight, good impact strength, resistance to oil, grease, and chemicals, and others, polyvinyl chloride (PVC) packaging material is used in a variety of end-use industries such as personal care, food and beverages, medical, and others.The scope and objective of the study are included in the PVC Packaging Materials Market research report. In addition, the report highlights the report's key market segments and players.
Flax Crop Market Growth with Worldwide Industry Analysis to 2027| Schweitzer-Ma …
Flax, often known as common flax or linseed, is a crop grown primarily in milder climates around the world. The scope and objective of the study are included in the Flax Crop Market research report. In addition, the report highlights the report's key market segments and players. It also discusses industry trends, with an emphasis on market use cases and top market size by region, as well as market trends

All 5 Releases


More Releases for Ascites

Global Ascites Needle Market Analysis by 2020-2025
Global Info Research offers a latest published report on Ascites Needle Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Ascites Needle Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/Global-Ascites-Needle_p510224.html Market
Global Ascites Market Healthcare Analysis 2018 to 2023
Global and Chinese  Ascites Industry, 2018 Market Research Report: The 'Global and Chinese  Ascites Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global  Ascites industry with a focus on the Chinese market. The report provides key statistics on the market status of the  Ascites manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Global Ascites Treatment Market Size, Status and Forecast 2018-2025
This report focuses on the global Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ascites Treatment development in United States, Europe and China. Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. North America and Europe together account for largest market
Ascites Market Import | Export Outlook and Global Foresight 2023
Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast,
Ascites Market 2018 - Opportunity, Driving Trends and deep study.
Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast,
Ascites Treatment Market Set to Surge Significantly During 2025
Peritoneal cavity is the space between lining of abdominal organs and abdomen. Accumulation of fluid in peritoneal cavity is refereed as ascites. In some cases, the condition is also referred as portal hypertension. Low levels of proteins (albumin) and portal hypertension i.e. high pressure in blood vessels of the liver results in ascites. Only 30% to 40% of the people suffering from ascites survive for around five years. Report Overview @